Kimberly Clark : KMB 1Q 2026 Earnings Presentation Slides (64bb24)

KMB

Published on 04/28/2026 at 06:52 am EDT

Q1 2026 Earnings

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

April 28, 2026

BABY CARE WOMEN'S HEALTH ACTIVE AGING

CORE BUSINESS MOMENTUM

GENERATIONAL VALUE CREATION OPPORTUNITY

KENVUE

ACQUISITION

Successfully Transforming Differentiated Capabilities Core Financial Strength

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 3

P OWERING CA RE

Q1 2026: Sustaining Strong Base Business Momentum

Out-Innovate | Out-Market

Out-Activate

Strong volume/mix-led

organic growth delivery

Held global weighted share in the quarter vs. baseline, while navigating a dynamic environment

Best Product, Lowest Cost

Continued momentum

on Gross Productivity

Managing input cost volatility while expanding operating margins

Fast & Agile

Operating Model

Overhead efficiencies driving

strong Adjusted RSG&A1 leverage

Efficiently and effectively navigating new, discreet headwinds

1Non-GAAP financial measures. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures.

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

4

Our Powering Care Strategy Is Sustaining Top-Line Momentum

Volume + Mix

2.6%

P OWERING CA RE

3.0%

Building on 2 consecutive years of broad-based volume-plus-mix growth

(0.7%)

1.0%

(1.6%)

FY22 FY23 FY24 FY25 Q1'26

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

5

We're Delivering a Surge

of Growth Initiatives in Q2

We're Delivering More and Faster Innovation Than Ever Before

P OWERING CA RE

OUT-INNOVATE

2024/2025

~60%

of total Net Sales from Innovation1

>75%

of Organic Growth from Innovation1

OUT-ACTIVATE

OUT-MARKET

2026

+50%

increase in

market reach for key

innovations2

2026 - 2028

1.6x

2x

Expected NSV contribution from Q2'26 launches3

Cumulatively across FY 2024 and 2025

2026 vs. 2022-2023 average

Q2 2026 NSV contribution vs 2022 - 2025 quarterly average.

2026 3 YR pipeline value vs. 2020

increasing 3YR

Pipeline Value4

6

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 6

Sustaining Industry-Leading Gross Productivity Savings

BEST

P RODUCT, LOWEST

COST

Q 1 2 0 2 6

On Track for 3rd Year of ~6% Gross Productivity Savings in 20262

of Adj COGS1

Value Stream:

Design to Value initiatives including standardized product platforms and strong price negotiations unlocking value

Network Optimization:

Optimizing manufacturing and distribution footprint including external contract manufacturing among others

Scalable Automation:

Gross Productivity includes Productivity generated from end-to-end Integrated Margin Management and from Procurement initiatives

Unlocking efficiencies through automation

1Non-GAAP financial measures. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures. 2Kimberly-Clark does not provide a reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures on a forward-looking basis because it is unable to predict certain adjustment items without unreasonable effort.

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 7

Building Momentum Toward Acquisition

Scaled Consumer Health &

Wellness Company with:

~$32B+

Revenue1

~$7B

Great Progress

Toward Day 1

Excited to establish

post-close leadership team, lean-and-agile organization structure

Encouraged by Kenvue

operational progress

Building greater visibility on future earnings power of combined company

EBITDA1 Pre-Synergies

Building the Future of Consumer-Centric Care for All

Leading

Baby Care

Pioneering

Active Aging

Advancing

Women's Health

Reflects the estimated 2025 results for the combined companies, as reported in the joint proxy statement/prospectus filed on form S-4 on December 4, 2025, and as amended on December 12, 2025. EBITDA Pre-synergies is a non-GAAP financial measure. Refer to the previously mentioned Form S-4 filings for further information on this non-GAAP financial measure.

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

8

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

SEGMENT RESULTS & HIGHLIGHTS

North America

Organic Growth1 Operating Profit Growth

1.8%

(8.1%)

Q1'26 Q1'26

Strong volume+mix led organic growth in a

challenging, value-conscious, consumer environment

Broad-based volume growth with strong performance in Baby and Child Care of +5%

Q1 weighted share broadly in line with year ago while personal care categories grew value share +20 bps led by volume share gains of +60 bps

Lower operating profit and margin versus strong year ago, as productivity savings and volume-driven gains were more than offset by a 490 bps headwind from business exits as well as stepped-up

brand investments

+1.7%

VOLUME + MIX

23.5%

OPERATING MARGIN

1. Non-GAAP financial measure. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures.

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 10

North America: Market Share + Margin Momentum

C O U N T R Y : C A T E G O R Y " C E L L " A S S E S S M E N T :

% O F N E T S A L E S G A I N I N G / H O L D I N G S H A R E 1

18 Cells, Net Sales Weighted2

Innovation to drive best

performance at the lowest cost

Breakthrough marketing to build

brand love

Differentiated value

propositions across price:value tiers, channels, and markets

23.7% 23.5%

32%

22.9%

67%

95%

2023 2025 Q1'26

1Share changed measured 2023 vs. 2022, 2025 vs 2023, Q1 2026 (MAT) vs 2025

2 Weighted K-C net sales based on FY 2025

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

11

U.S.: Driving Growth in Facial Tissue with Kleenex Innovation

OUT-

INNOVA TE

1. g

U.S. FACIAL TISSUE

+180 bps

L3M Market Share vs.

year ago

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 12

"Don't Be Afraid":

Breaking the Stigma with Depend

OUT-MA RKET

U.S. DEPEND1

+80 bps

L3M Market Share vs. year ago

+190 bps

L3M Consumption Growth Ahead of Category

Deion Sanders

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

Coach Prime

1 Values based on All Outlet data for Adult Care HE

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 13

OUT-

INNOVA TE

U.S.: End-to-End Kotex Relaunch Leveraging Breakthrough Gravity Technology

GRAVITY SCALED IN TOP MARKETS AND ENTERPRISE MARKETS

Powered by Gravity Core Technology

*breathability, odor control, dryness, fit, and leakage protection

Rapidly pulls blood to the bottom of the pad to help women feel clean, dry, and protected

5X System with LeakShield

Delivers breathability, odor control, dryness, fit, and reliable leak protection

Bamboo

UltraSoft and breathable viscose top layer made from organically-grown bamboo

BioCare

pH Proactive System helps defend against odor and irritants

Night DefenseĀ®

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

Designed with revolutionary side guards and a raised back bumper to help prevent back and side leaks

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

14

"Own Your Flow":

New Global Kotex Platform

OUT-MA RKET

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 15

International Personal Care

Organic Growth1 Operating Profit Growth

21.9%

4.0%

Strong volume+mix led organic growth with Focus Markets +5% and Enterprise Markets +2%

Baby Care in Focus Markets grew double-digit organic growth in the quarter

Continued share momentum in Focus Markets led by growth in Diapers C Pants in Indonesia +320 bps, China

+180 bps, Brazil +40 bps; Indonesia Fem Care +310 bps, and Australia Adult Care +230 bps

Strong operating profit growth driven by productivity

gains, volume-driven net sales growth, and overhead

Q1'26

Q1'26

efficiencies

+5.5%

VOLUME + MIX

16.2%

OPERATING MARGIN

1. Non-GAAP financial measure. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures.

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 16

International Personal Care: Market Share + Margin Momentum

% O F N E T S A L E S :

K E Y C E L L S G A I N I N G / H O L D I N G S H A R E 1

c1 Cells, Net Sales Weighted2

16.2%

84%

59%

52%

11.3%

14.0%

Innovation to drive best

performance at the lowest cost

Breakthrough marketing to build

brand love

Differentiated value

propositions across price:value

tiers, channels, and markets

2023 2025 Q1'26

1Share changed measured 2023 vs. 2022, 2025 vs 2023, Q1 2026 (MAT) vs 2025

2 Weighted K-C net sales based on FY 2025

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S

17

OUT-

INNOVA TE

Breakthrough material innovation with clear absorbency and

breathability benefits to keep babies drier and more comfortable.

Consumer Satisfaction

Product Rating

Breathability

300 Air Holes

Refreshing comfort with airflow

Absorbency

300 Instant Absorption Pockets with Max

Absorption Tech

Proven Product Superiority

Preferred

vs. Leading Competitor

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 18

Indonesia: Winning in Premium and Driving Performance Across Diapers Tiers

First in Indonesia!

OUT-

INNOVA TE

Indonesia Diapers s Pants

+320 bps

L3M Market Share vs. year ago

2 Special Zones to Separate Pee C Poo for No-Worry Irritation

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 19

Brazil: Taking Diapers

Share and Scaling Innovation

OUT-

INNOVA TE

2025 marked a milestone year enabled by portfolio relaunch

+1.9PP

Brand Equity

+22%

Premium growth sales

+40

bps

L3M Market Share vs year ago

Value Market Share

20.5

20.2

20.8 21.0

FY' 23 FY'24 FY'25 L3M '26

K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 20

K I MBE R L Y - CL ARK | Q1 2 0 2 6 E ARN I NGS

Disclaimer

Kimberly-Clark Corporation published this content on April 28, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 28, 2026 at 10:51 UTC.